Introduction
Pulmonary embolism (PE) is a common but potentially fatal condition and one of the leading causes of sudden death in the western world. Although the true incidence of PE is unknown, it is estimated that over 100,000 cases in France, 65000 cases among hospitalized patients in England and Wales and at least 600,000 cases in USA occur per year. Although the basic patho-physiology of a pulmonary embolism is understood for many years, the morbidity and mortality associated with this disease remains unacceptably high. Alikhan et al carried out a retrospective review of all postmortem reports during the period 1991 to 2000 at King's College Hospital, London and fatal pulmonary embolism was recorded as cause of death in 265 out of 6833 cases (3.9% of all necropsies; 5.2% of adult cases) 1 . Mortality in untreated PE is approximately 25-30%, but with adequate treatment, this can be reduced to 2-8% [2] [3] . Over all mortality reported in International Cooperative Pulmonary Embolism Registry (ICOPHER) study was 45%, whereas 3-month mortality rate for all pulmonary embolism was as high as 17.4% 4 . Patients with stable PE sometimes do well without treatment 5 . Unfortunately, the diagnosis of PE remains a complex and challenging process for clinicians and radiologists alike. Much of the difficulty in the diagnosis of PE arises from nonspecific clinical presentations, coupled with a host of diagnostic options which all possess inherent limitation. 10 reviewed the data from Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) I study and found 30% patient with no cardiopulmonary disease and 14% patient with prior cardiopulmonary disease had PE with normal arterial blood gas (ABG). Pulse oximetry is extremely insensitive, is normal in the majority of patients with PE, and should not be used to direct a diagnostic workup. Cardiac troponin I may be a useful marker to suggest right ventricular involvement and may indicate increase mortality [11] [12] [13] . Similarly raised Brain natriuretic peptides (BNP) may reflects right ventricular overload and predict in hospital complication and mortality 14 .
Electrocardiogram (ECG)
The most common ECG abnormalities in the setting of PE are tachycardia and nonspecific ST-T wave abnormalities. Any other ECG abnormality may appear with equal likelihood, but none are sensitive or specific for PE.
Table-VII :
Common ECG findings in PE Unfortunately, only 20% of patients with proven PE have any of these classic ECG abnormalities. The most common electrocardiographic abnormalities were nonspecific T wave changes which occurred in 42% of patients and nonspecific abnormalities (elevation or depression) of the RST segment which occurred in 41% of patients 15 . The anterior subepicardial ischemic pattern is the most frequent ECG sign of massive PE and early reversibility indicates a good outcome 16 . Reversible prolonged Q-T interval may be present in a patient with pulmonary embolism 17 . In massive embolism, the electrocardiogram was normal in 6% (3 of 50) of patients. With submassive embolism, 23% of patients (9 of 40) had a normal electrocardiogram 15 
Diagnostic Modalities
No single imaging study or blood test is 100% sensitive and specific for pulmonary embolism. A combination of pretest clinical probability assessment, noninvasive pulmonary imaging [ventilation-perfusion(V-P) scanning or spiral computed tomography (CT)] and d-dimer testing seems prudent before pursuing pulmonary angiography. In a recent review of patients with pulmonary embolus and no pre-existing cardiac or pulmonary disease, only 16% of the chest x-rays were normal 23 . Atelectasis and/or pulmonary parenchymal abnormalities were most common findings (68%) and only 6% had the Westermark sign 23 . Elliot et al reviewed the International Cooperative Pulmonary Embolism Registry (ICOPER) database and found cardiomegaly was reported most common x-ray findings 24 . In the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) study, pleural based wedged shaped infiltrate, oligemia and abrupt cut off of hilar vessels appeared to be closely associated with PE and were present in 15% -45% of patients 25 .
Echocardiography
Right ventricular failure is the ultimate cause of death in patients who succumb to acute PE. Presently ,echocardiography and doppler analysis of right heart dimensions and RV function permits neither definitive confirmation nor exclusion of suspected PE. However, hemodynamically important PE is unlikely in a patient with a normal echocardiogram.
Table-VIII: Echocardiographic features of PE
This finding has been shown to correlate not only with larger emboli but also recurrence of PE. Those who have above changes on echocardiography with or without features of shock could benefit from thrombolytic therapy. Echo features such as right ventricular (RV) free wall thickness >5mm, tricuspid reugitant jet velocity >3.7 m/s and dilated RV with normal interventricular septal motion may also helpful to differentiate acute from subacute massive PE 26 . Relative sparing of the right ventricular apex , known as McConnell sign sometimes useful to differentiate between right ventricular dysfunction due to PE or due to other condition 27 . Pruszczyk et al studied 49 patients with suspected massive pulmonary embolism and found that sensitivity of Trans esophageal echo (TEE) was 80% for detecting PE of any size and specificity was 100% 28 . In one study, 92% of patient with 30% or more impaired lung perfusion develop right ventricular hypokinesia 29 . Mortality is increased in patient with right ventricular involvement which sustained up to three months after diagnosis of PE. Right ventricular dysfunction may provide a powerful predictor of inhospital death, with a 6-fold increase in relative risk compared with normal right ventricular function 30 . Similar results were obtained in ICOPER 4 . Overall, 5% developed related to the severity and outcome of pulmonary embolism. New onset right bundle branch block (RBBB) may indicate massive obstruction of the main trunk 18 . Right sided ECG may be helpful in identifying RBBB in presence of normal 12 lead EKG 19 . If ECG abnormalities are present, they may be suggestive of PE, but the absence of ECG abnormalities has no significant predictive value.
d-dimer
Plasma d-dimer, a degradation product of cross-linked fibrin can be measured by three method -ELISA, Latex and Whole agglutination (SimplyRED) tests. When assayed by a quantitative ELISA method has been shown highly sensitive ( more than 95%) in VTE at a cutoff value of 500 ng/ml but specificity remains low (55%) as fibrin is produced in a wide variety of conditions, such as cancer, inflammation, infection, necrosis. Hence, a ddimer level above 500 ng/ml has a poor positive predictive value for PE. In a prospective study involving 96 patient over 70 years old without history of metastatic cancer or recent surgery, trauma, infection, stroke, myocardial infarction, deep vein thrombosis (DVT) or PE found that ELISA d-dimer is as sensitive as in adult population but due to the comorbid conditions, only a few patients presented with d-dimer values less than 500 ng/ml 20 . A normal d-dimer level by ELISA assay may safely exclude PE but traditional latex and whole agglutination tests should not be used to rule out PE. A study comparing d-dimer with tissue plasminogen activator (tPA), using a cutoff of 8.5 ng/mL, showed that the sensitivity and negative predictive value of d-dimer were low compared with tPA 21 . Kucher et al 22 tested the hypothesis that ratio of d-dimer/Fibrinogen (D/F) may be more specific than d-dimer alone. Their study showed that the true positive rate was almost twice as high using D/F ratio >1.04 x 103 (49 of 85 patients; 57.6%) compared with d-dimer >7000 micro g/L (25 of 85 patients; 29.4%). In summery, d-dimer is an important diagnostic tool when index of suspicion for PE is low and in the setting of high clinical probability, physician should order a more specific test rather that wasting time on d-dimer.
Chest Radiograph
The value of obtaining preliminary chest X-ray (CXR) in the workup of PE is in ruling out conditions that might be confused with PE and identifying coexisting cardiopulmonary processes that might interfere with the interpretation of V/Q scan. alone is 44% and increase to 62% when combined with V-P scan 35 . Similar results showed in a study by Daniel et al even in a best-case scenario 36 .
Ventilation-Perfusion (V-P) Scan
V-P scan have long been a mainstay in the workup of patients with suspected PE. The reason for this are two fold: it is a non-invasive diagnostic technique and it has been evaluated in extensive clinical trials. PIOPED I 37 study has established the value of V-P lung scan. The prevalence of PE with normal perfusion scan is so small (<0.2%) that a normal scan virtually excludes the diagnosis. Similarly, the likelihood of PE with low probability results is estimated to be 4%. Whereas a high probability V-P scan is considered diagnostic in the setting of appropriate clinical scenario. But unfortunately large fraction of V/Q scan (60 to 70%) resides in a grey area that is characterized by either indeterminate or intermediate probability interpretation. Approximately 25% of patients with suspected PE will have the diagnosis refuted by a normal perfusion scan and anticoagulants may be safely withheld. Around 25% of patients with suspected PE will have a high probability lung scan and anticoagulant may be instituted. The remaining patients will require further diagnostic tests as those patient have a 20% to 40% prevalence of angiographically proven PE. The 67% specificity and 61 to 70% interobserver agreement rates illustrate the diagnostic limitations of these scans 38 . Gotthardt et al 39 found, out of the 129 patients receiving a scintigraphic follow-up, only 29 (22.5%) had a follow-up over more than 1 year, 19 of those had persisting perfusion defects. It is concluded that an inadequate scintigraphic followup of patients with pulmonary embolism which may lead to unnecessary anticoagulant treatment if persisting perfusion defects are misinterpreted as fresh pulmonary embolism 39 . Ventilation-perfusion scanning provides a definitive diagnosis in fewer than 40% of cases 37, 40 . These limitations may explain why clinicians often do not pursue definitive objective tests for suspected pulmonary embolism [41] [42] [43] . Abnormal X-ray chest (CXR) or chronic lung disease is another diagnostic challege for V-P scan. Scot et al found that computer-based V-P scan (Using ANN) analysis performs comparably to clinical interpretation for patients with abnormal chest radiographs 44 . Stein et al conducted study in a population with or without cardiac or pulmonary disease and results of V-P. They found the utility of V-P scan was not impaired in presence of pre-existing cardiac or pulmonary disease except fewer patien without history of cardiopulmonary disease had intermediate V-P scan 45 . Retrospectively analyzed up to one year of follow-up in 90 patients who were clinically suspected of having PE, but in whom V-P scintigraphy implied a low probability of PE. None of the 90 patients demonstrated clinical evidence of PE subsequent to the V-P scan 46 . In PISA-PED, they prospectively evaluated 890 consecutive chronic pulmonary hypertension. Some authors suggest follow up TEE has been utilized to document emboli in the main or right pulmonary artery. At present, the role of transthoracic Echo for the diagnosing of acute PE remains undefined and can't be considered a first line diagnostic tool for investigation of PE. But certainly will influence the treatment and outcome/prognosis.
Venous Doppler Ultrasound
Since PE is a complication of deep vein thrombosis (DVT). Most of the data showed that 90% of PEs originates from lower extremity DVT, doppler ultrasonography often has an instrumental role in the workup of suspected PE. Duplex scan only reliably identify DVT in the thigh and groin (sensitivity and specificity in symptomatic patient 95 and 98% respectively) and are poor in visualizing pelvis and calf veins. One study 31 evaluates the utility of venous duplex imaging as the initial test in a diagnostic algorithm for patients with suspected PE. With unilateral leg symptoms, DVT was found in 40% and without unilateral leg symptoms, results of venous duplex imaging (VDI) were abnormal in only 5% 31 . DVT was found in 25% of patients with high-probability V-P scans and in 25% with non-highprobability scans and conclusion was VDI appears to be a reasonable initial screening test in patients with clinically suspected PE and unilateral leg symptoms 32 . Retrospective study involving 136 patients, comparing VDI with computed tomography venography (CTV) found CTV is less sensitive and more costly than VDI 30 . Overall, lower extremity sonography only detects DVT in approximately 50% of patients with documented PE.
Another limitation of sonography is to differentiate between acute vs chronic DVT. Findings suggestive of chronicities includes collateral vein, small caliber vein, irregular vessel wall, increased clot echogenicities 33, 34 . Serial leg testing may replace angiography in patients with non-diagnostic lung scan findings. However, its practical use seems limited. In one study with non-high probability V-P scan, they found that sensitivity of lower extremities colour flow venous duplex examination. Table- . A prospective study by Friera et al, out of the 99 patients, 9 (9%) died during the 9-month follow-up, the cause of death in each case was not due to thromboembolic venous disease. No venous thromboembolic events were detected in the other 90 patients 58 . Similar results were reported in other studies [59] [60] [61] [62] [63] . The most reliable and basic criterion for the diagnosis of acute pulmonary embolism is the finding of an intraluminal filling defect. When contrast medium can flow around a central clot, the appearance is either of a "rail track" if the arteries lies parallel and within the scan plane or a "polo mint" if the artery runs perpendicular to the scan plane. Combined CT venography and pulmonary angiography was first tried in 1998 and since then this imaging methods is gaining popularity. PIOPED II study has been initiated to look at it's efficacy 64 . Preliminary results suggest the spiral CT and venous phase CT may becomes a first line diagnostic tools in evaluating pulmonary embolism. Advantages of combined CT venography and pulmonary angiography is that visualization of chest and extremities in one go, better accuracy in the evaluation of iliac veins, Inferior vena cava (IVC), and vessels poorly seen on sonography. CTVPA has now been studied by multiple researchers and showed very promising results and may become choice of procedures in future [65] [66] [67] .
Magnetic Resonance Imaging (MRI)
MRI has not been considered as a popular imaging method and the reason to put it down as signal loss due to cardiac pulsation and respiration, susceptibility artifacts caused by multiple air-tissue interfaces and low proton density. Recently, further improvements in MRI techniques have widened the potential for investigations of pulmonary disease. MRI is now being utilized to evaluate clinically suspected PE. The technique is rapid, accurate, avoids nephrotoxic iodinated contrast and is better accepted by patient than pulmonary angiography. There are more data available for diagnosing by spiral CT than by MRI at the present time but MRI has several attractive advantages, including excellent sensitivity and specificity for the diagnosing of DVT together with the potential for performing perfusion imaging. This technique may ultimate allow the simultaneous and accurate detection of both PE and DVT. Sostman et al 68 reported in their study that the average sensitivity of CT was 75% and of MR 46%; the average specificity of CT was 89% and of MR 90% and the conclusion was CT and MRI had similar accuracy for detecting pulmonary embolism. MRI can be useful in certain conditions namely pregnancy, pelvic vein thrombosis, pelvic malignancy, brachiocephalic and superior vena caval thrombosis. MRI is particularly helpful to recognize chronic DVT 33, 69 . Lack of wide availability, difficult portability, high expenses and very few studies limits MRI as a first diagnostic tool for VTE at present. patients with suspected pulmonary embolism. Of 890 scan, 670 were classified as abnormal. A definitive diagnosis was established in 563 (84%) patients with abnormal scans and the conclusion was accurate diagnosis of pulmonary embolism is possible by perfusion scanning alone, without ventilation imaging 47 . In a report by Reinartz and his colleagues 48 , V-P lung scintigraphy using SPECT and ultrafine aerosols technique and helica CT are comparable diagnostics accuracy.
CT Scan
Until the early 1990, the only imaging techniques available for evaluating pulmonary circulation were ventilation-perfusion scintigraphy and pulmonary angiography. Kalender et al first reported the benefits of spiral CT in 1990 and since the the pioneering study by Remy-Jardin et al in 1992 there have been several large studies specifically evaluating the diagnostic accuracy of spiral computed tomographic pulmonary angiography (SCTPA). Spiral CT angiography is an accurate means of diagnosing pulmonary embolism with sensitivity and specifity in the region of 86% to 100% and 78% to 96% respectively [49] [50] [51] . Garg et al studied 44 patients with suspected pulmonary embolism and all underwent both V-P scan and spiral CT. Compared both results with pulmonary angiography. They didn't only found the Spiral CT has greater accuracy and specificity than V-P scanning in patients but also found that CT provides alternative diagnosis in 31% of patient 52 . All the large studies that have evaluated the accuracy of CT have been restricted to the identification of emboli within the central, lobar and segmental arteries with sensitivity of 86% 50, 51, 53 . The prevalence of small sub-segmental emboli remains debatable with varying frequencies. Stein and colleagues 53 found based on data from all patients with PE in PIOPED, the prevalence of PE limited to subsegmental pulmonary arteries is low, 6%. A spiral CT angiography is currently unable to identify reliably emboli within pulmonary arteries below the fourth generation with sensitivity of only 30% 51, 53 . In a report by Remy Jarden and colleagues, visualization of subsegmental vessels were much better with a scanner equipped with 3-mm collimation than with 2-mm collimation 54 . Scanner equipped with 1-mm collimation increased the yield by 40% and also improved the inter-observer agreement 55 . Meta-analysis by Moores and colleagues, reviewed all published studies that used Computed tomography pulmonary angiography (CTPA) to evaluate suspected PE and reported at least 3 months of follow-up in patients not receiving anticoagulation on the basis of a negative CTPA result. The rate of subsequent venous thromboembolism after negative results on CTPA is similar to that seen after negative results on conventional pulmonary angiography. It appears to be safe to withhold anticoagulation after negative CTPA results 56 .
In an another retrospective study by Nilsson and colleagues, only 4 patient out of 441 with initial negative CTPA and no DVT symptoms develop VTE during 3-
Conclusion
Until 1990, diagnosis of PE was a challenge and remained undiagnosed with noninvasive diagnostic tools. With the advances of technology and introduction of d-dimer testing, pulmonary embolism is diagnosed more frequently and negative test virtually rule out PE. CT pulmonary angiography is becoming the standard of care at many institutions for the evaluation of patients with suspected pulmonary embolism. But question raised about the effectiveness of spiral CT in the diagnosis of PE in critically ill patients 70 and warrant further study in that particular population. There is increasing evidence that MRI could be useful tool in the diagnosis of PE, specially when intravenous contrast is contraindicated but more researches are needed. Increasing use of noninvasive methods as an additional means in pulmonary embolism diagnostics may in most cases spare the use of pulmonary angiography.
